SHARE:  

Update from Capitol Hill: Copay Accumulators

In a September 29 opinion in HIV and Hepatitis Policy Institute et al. v. U.S. Department of Health and Human Services et al., the District Court for the District of Columbia struck down the regulation allowing the use of copay accumulators in the exchanges. In addition to the HIV and Hepatitis Policy Institute, plaintiffs included the Diabetes Leadership Council, the Diabetes Patient Advocacy Coalition, and three individual patients harmed by their insurers’ use of copay accumulators. Back in February, CSRO supported the plaintiffs by joining the Aimed Alliance’s amicus brief, so the ruling came as welcome news.

 

It's important to note that the recent court opinion does not outlaw the use of copay accumulators across the board. Rather, the judge struck down the 2021 Notice of Benefit and Payment Parameters (NBPP) that allowed insurers to use copay accumulator programs in the Affordable Care Act exchanges, but the ruling left open the possibility for the agency to reissue a proposal on this topic in the future. For now, insurers must abide by the 2020 NBPP, which allowed the use of accumulators only for branded drugs with low-cost therapeutic alternatives.

 

The opinion left some question as to the continued need for the HELP Copays Act, which would prohibit the use of copay accumulators in the exchanges – a policy that CSRO strongly supports. The legislation remains necessary for two main reasons:

  1. As noted above, the court ruling leaves open the door for the agency to readdress this issue in the future in a way that would allow for the use of copay accumulators in the exchanges, and the HELP Copays Act would firmly close that door.
  2. The legislation has another component that would close the essential health benefits loophole, by which some insurers designate expensive specialty medications as “non-essential health benefits.” This issue was not addressed by the court ruling and remains in need of a legislative solution.


CSRO will continue to push for advancement of the HELP Copays Act, and has recently joined a letter by the All Copays Count Coalition, urging the Administration not to appeal the recent ruling. Further updates will be shared as appropriate.

Input Requested: MIPS Adjustments Impact on Rheumatology Practices

CSRO has heard from practices that received unexpectedly low scores in the MIPS program and face a penalty in 2024, largely due to their performance on the Total Per Capita Cost (TPCC) measure in the Cost performance category.


To gain a better understanding of the issue, CSRO is requesting input from practices who have experienced this issue, especially if a practice has historically been successful in the program (and in the Cost category in particular), but now face a penalty.


If your practice has been adversely impacted, please email info@csro.info to let us know and share your 2019 and 2022 feedback reports.

Share Input

CSRO Member Breakfast: Join Us in November

Join CSRO during ACR Convergence 2023 in San Diego for an Exclusive Member Breakfast on Sunday, November 12 to converse with others in the rheumatology community about challenges you may be facing and to discuss your state society's priorities for the year. Registration is required – sign up now!

Exclusive Member Breakfast

Sunday, November 12

7:00am PT

Register Now

Please note: this is not an official function/event of the American College of Rheumatology.

Opportunities From Our Partners

RRF Workforce Expansion Award

The Rheumatology Research Foundation (RRF) offers a Mentored Nurse Practitioner/Physician Assistant Award for Workforce Expansion to increase the supply of rheumatology healthcare providers to better meet the needs of people with rheumatic diseases across the United States, particularly in geographically underserved areas.


This award provides $25,000 of support to provide tailored training for nurse practitioners or physician assistants who are new to the field of rheumatology.


Applications for the next cycle of funding are due December 1, 2023 - more details and information on how to apply can be found here.

ARP Advanced Rheumatology Courses

The Association of Rheumatology Professionals (ARP) offers an Advanced Rheumatology Course (ARC) which is a comprehensive, 19-module educational series geared toward members of the rheumatology interprofessional team and other professionals needing a deeper dive into rheumatology. 


More details, including an overview of each course, are available here.

Do you have activities you'd like us to share? Send us an email at info@csro.info.

Legislation Around the Country

What's Happening in the States

CSRO tracks legislative activity relevant to the rheumatology community and their patients. Check out the list below to see the status of CSRO priority bills from the past two weeks, and click here to view a full status report of CSRO priority bills.


Be sure to check out our interactive legislative map tool for additional details.

View Status Report

OHIO

Accumulators 

  • HB 177: Proponent testimony heard

Non-medical Switching

  • HB 291: Introduced and referred to Insurance committee

CSRO Resources for You

Action Center

Use CSRO's convenient online platform to easily find out who your elected officials are and engage with them directly.


Advocacy Council

Amplify your voice by assembling with other like-minded individuals to enhance CSRO’s advocacy initiatives.


Legislative Map Tool

Find your state on our interactive map tool to learn about current or proposed policy and ways you can take action to make an impact.


Rheum for Action

Learn about the latest advocacy issues in CSRO's advocacy column produced in partnership with Rheumatology News.


Payer Issues Reporting Form

Request assistance with any payer relation issues that may be impacting your patients or office.


Policy Correspondence

Easily access all of CSRO’s policy letters submitted to payers, state, and federal governments as an informational resource.


Step Therapy Cover Sheets

Review CSRO's state-specific step therapy materials that help guide practices in gaining an exemption from step therapy protocols.

CSRO is a 501c3 nonprofit organization that has remained dedicated to ensuring access to the highest quality care since 2003  donate today.

Give Now

Questions?

Please visit the CSRO website for other news and updates, and do not hesitate to contact us with any questions at info@csro.info.

Twitter  LinkedIn  Facebook  Email  Web